Whole Exome Sequencing Study Identifies Distinct Characteristics of Transformed Small Cell Lung Cancer With <scp>EGFR</scp> Mutation Compared to De Novo Small Cell and Primary Non‐Small Cell Lung Cancers
Whole Exome Sequencing Study Identifies Distinct Characteristics of Transformed Small Cell Lung Cancer With <scp>EGFR</scp> Mutation Compared to De Novo Small Cell and Primary Non‐Small Cell Lung Cancers is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Whole Exome Sequencing Study Identifies Distinct Characteristics of Transformed Small Cell Lung Cancer With <scp>EGFR</scp> Mutation Compared to De Novo Small Cell and Primary Non‐Small Cell Lung Cancers have?
Whole Exome Sequencing Study Identifies Distinct Characteristics of Transformed Small Cell Lung Cancer With <scp>EGFR</scp> Mutation Compared to De Novo Small Cell and Primary Non‐Small Cell Lung Cancers has 5 citations in the OpenAlex counts ScholarIQ stores.
When was Whole Exome Sequencing Study Identifies Distinct Characteristics of Transformed Small Cell Lung Cancer With <scp>EGFR</scp> Mutation Compared to De Novo Small Cell and Primary Non‐Small Cell Lung Cancers published?
Whole Exome Sequencing Study Identifies Distinct Characteristics of Transformed Small Cell Lung Cancer With <scp>EGFR</scp> Mutation Compared to De Novo Small Cell and Primary Non‐Small Cell Lung Cancers has 2025 year in the ScholarIQ index.
What is the open-access status of Whole Exome Sequencing Study Identifies Distinct Characteristics of Transformed Small Cell Lung Cancer With <scp>EGFR</scp> Mutation Compared to De Novo Small Cell and Primary Non‐Small Cell Lung Cancers?
Whole Exome Sequencing Study Identifies Distinct Characteristics of Transformed Small Cell Lung Cancer With <scp>EGFR</scp> Mutation Compared to De Novo Small Cell and Primary Non‐Small Cell Lung Cancers has gold oa status in the ScholarIQ index.
What is the DOI of Whole Exome Sequencing Study Identifies Distinct Characteristics of Transformed Small Cell Lung Cancer With <scp>EGFR</scp> Mutation Compared to De Novo Small Cell and Primary Non‐Small Cell Lung Cancers?
The DOI for Whole Exome Sequencing Study Identifies Distinct Characteristics of Transformed Small Cell Lung Cancer With <scp>EGFR</scp> Mutation Compared to De Novo Small Cell and Primary Non‐Small Cell Lung Cancers is on the source record.
What is the PMID of Whole Exome Sequencing Study Identifies Distinct Characteristics of Transformed Small Cell Lung Cancer With <scp>EGFR</scp> Mutation Compared to De Novo Small Cell and Primary Non‐Small Cell Lung Cancers?
The PMID for Whole Exome Sequencing Study Identifies Distinct Characteristics of Transformed Small Cell Lung Cancer With <scp>EGFR</scp> Mutation Compared to De Novo Small Cell and Primary Non‐Small Cell Lung Cancers is on the source record.
What is the OpenAlex record for Whole Exome Sequencing Study Identifies Distinct Characteristics of Transformed Small Cell Lung Cancer With <scp>EGFR</scp> Mutation Compared to De Novo Small Cell and Primary Non‐Small Cell Lung Cancers?
The OpenAlex for Whole Exome Sequencing Study Identifies Distinct Characteristics of Transformed Small Cell Lung Cancer With <scp>EGFR</scp> Mutation Compared to De Novo Small Cell and Primary Non‐Small Cell Lung Cancers is on the source record.